Clinical Trials Directory

Trials / Completed

CompletedNCT03831555

Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic

Use of a Psychosocial Readiness Tool to Improve Hepatitis C Treatment Adherence and Outcomes at the Grady Liver Clinic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn more about what psychological and social factors affect people in how they take their hepatitis C medications.

Detailed description

The goal of this study is to determine if a qualitative survey that assesses a patient's readiness for treatment of Hepatitis C (HCV) and associated interventions based on identified barriers can improve treatment adherence and outcomes. HCV remains a leading cause of liver cancer and end stage liver disease despite greater than 90% cure rates with new, all-oral antiviral medications. While these new medications are easier to tolerate and access than previous treatment regimens, medication adherence still remains a great barrier to cure. In this study, we will administer the Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) tool, a free, online survey developed at the Mount Sinai School of Medicine to determine psychosocial readiness for treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPREP-CThe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) tool assesses a patient's psychosocial readiness to start HCV treatment. There are nine sections in the survey: 1. Motivation: reasons client wants to begin HCV treatment, concerns about treatment, and the importance of treatment 2. Information: knowledge about HCV treatment and one's own HCV disease status 3. Medication Adherence: current prescribed medications and adherence to them in the prior month 4. Self-efficacy: self-confidence about adhering to HCV treatment 5. Social Support and Stability: stability of financial, housing, and social support resources 6. Alcohol and substance use: alcohol and substance use behaviors and current treatment 7. Psychiatric Stability: current psychiatric status, previous and current treatment 8. Energy Level: sleep and fatigue 9. Cognitive Functioning: perceived difficulty with communication in health care setting, problem-solving ability, and memory.

Timeline

Start date
2017-06-05
Primary completion
2018-05-01
Completion
2018-06-30
First posted
2019-02-06
Last updated
2019-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03831555. Inclusion in this directory is not an endorsement.